Least Shorted S&P 500 Stocks in December
Analysts Offer Insights on Healthcare Companies: Insmed (INSM), Gilead Sciences (GILD) and Abbott Laboratories (ABT)
FDA Bans Red Dye No. 3 Effective January 2027, Cites Cancer Risks: Food Stocks To Watch
FDA Expected to Issue Ban on Red Dye No. 3
Abbott Laboratories (ABT) Is Attracting Investor Attention: Here Is What You Should Know
ARAY Stock Gains as China Approves Latest Radiation Therapy Solutions
Abbott Laboratories Insiders Sell US$3.0m Of Stock, Possibly Signalling Caution
TEM Stock Declines Following Preliminary Q4 Sales Miss
Returns At Abbott Laboratories (NYSE:ABT) Are On The Way Up
Abbott Laboratories To Go Ex-Dividend On January 15th, 2025 With 0.59 USD Dividend Per Share
January 13th (Eastern Time) - $Abbott Laboratories(ABT.US)$ is trading ex-dividend on January 15th, 2025.Shareholders of record on January 15th, 2025 will receive 0.59 USD dividend per share on
Insulet Begins Commercial Sales of Omnipod 5 Insulin Delivery System in 5 More Countries
Digital Breast Tomosynthesis Market to Cross $12.3 Billion in Revenues by 2035, Dominated by Philips Healthcare, Medtronic, GE Healthcare, Honeywell Life Sciences, and Abbott Laboratories
Bernstein Maintains Abbott Laboratories(ABT.US) With Buy Rating, Cuts Target Price to $136
8 Health Care Stocks Whale Activity In Today's Session
Implantable Neurostimulation Devices Market Research 2024-2028 & 2033, Competitive Analysis of Major Players - Abbott Laboratories, Medtronic, Boston Scientific, Dignity Health, & St. Jude Medical
Bernstein Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $138
RBC Capital Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $135
Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst
Wells Fargo Sticks to Their Buy Rating for Abbott Laboratories (ABT)
FDA Issues First Draft Guidance on Use of AI in Drug, Medical Device Development